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Chapter 4
G-Protein-Coupled Receptors (GPCRs) as
Biopesticide Targets: A Focus on Octopamine
and Tyramine Receptors
Aaron D. Gross,1,2 Michael J. Kimber,2,† and Joel R. Coats*,1,†
1Pesticide Toxicology Laboratory, Department of Entomology,
Iowa State University, Ames, Iowa
2Department of Biomedical Science, Iowa State University, Ames, Iowa
†Co-senior authors
*E-mail: jcoats@iastate.edu.
Plants have evolved beneficial and protective mechanisms
including the production of essential oils. Essential oils are
the odiferous component of plant extracts, which give plants
a variety of unique properties. Essential oils are composed of
various terpenoid compounds, particularly monoterpenoids and
related aromatic compounds, along with sesquiterpenoids. A
variety of terpenoids have been shown to have a toxic effect
against insects. It is thought that this toxic action occurs through
a neurological mechanism of action. Octopamine receptors and
tyramine receptors are G-Protein-Coupled Receptors (GPCRs)
primarily found in invertebrates, including insects. GPCRs
have been a popular target for pharmaceutical development
but not for agrochemical development. A summary of insect
octopaminergic and tyraminergic systems is discussed.
The Need for Safe and Effective Insecticides
The growing world population, which is estimated to be around 9 billion
by 2050, is placing growing demands on agriculture. The agrochemical
and animal health industries are trying to discover new methods to control
economically devastating pests, like insects and ticks, along with the diseases
these organisms are capable of vectoring. Discovery of agrochemicals and
© 2014 American Chemical Society
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veterinary external-parasiticides has become difficult in a changing landscape
of agricultural practices characterized by increased public and governmental
scrutiny and demands. Such stipulations for agrochemicals include the discovery
of compounds having characteristics of decreased toxicity to non-target vertebrate
and invertebrate organisms, along with decreased environmental contamination.
While significant advances have been made in reducing the use rate and
environmental impact of conventional synthetic pesticides, biopesticides do
not share an equal amount of the market (1). Additionally, biologically-based
technology to aid in controlling agricultural pests still lacks public acceptance,
and is not as globally accepted outside of the United States. Further restraints
on agrochemical development include increased product costs and time to get a
product to market (1). Currently, agricultural pests are controlled by over 900
types of chemistry that have over 100 mechanisms of action (2). However, even
with this vast chemistry and mechanisms of action there is still a desideratum for
new mechanisms of action. It is important to note that new mechanisms of action,
along with new chemistry, are only successful with proper pesticide use and the
use of integrative approaches to pest control.
New Agrochemical Targets: G-Protein-Coupled Receptors
(GPCRs)
G-Protein-Coupled Receptors (GPCRs) are membrane-bound receptors,
which are involved in the sensing of extracellular signals. In turn, the extracellular
signal is internalized to result in some physiological or cellular response. This
very nature of GPCRs allows them to be highly “druggable” targets, and they
have been widely exploited by the human pharmaceutical industry. It is estimated
that as much as 50% of all human pharmaceuticals target GPCRs, which indicates
their vast importance to normal cellular and physiological functions and their
susceptibility to pathological conditions (3). However, GPCRs historically have
not been a dominant force in the agrochemical market. Recently, there has been
growing interest in the discovery of agrochemicals targeting GPCRs (3–6).
Several ligands can activate GPCRs; here we will focus on biogenic amines
as ligands for GPCRs, specifically tyramine and octopamine, and their importance
to invertebrate function, particularly in relation to insects. Another significant
class of ligands that are capable of activating GPCRs are neuropeptides. The
physiological importance of neuropeptides in D. melanogaster has been recently
reviewed (7). Since GPCRs are important to the pharmaceutical industry, there
have been several systems developed to study GPCRs, which have also been
previously reviewed (3, 4, 6, 8).
Octopamine and Tyramine Synthesis
Octopamine and tyramine are biogenic monoamines that are found in the
nervous system of arthropods, including ticks and insects. Octopamine and
tyramine were originally identified in the salivary glands of the octopus (9).
Octopamine and tyramine are catecholamines like dopamine, norepinephrine
46
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(noradrenaline) and epinephrine (adrenaline). Other biogenic amines include the
indolamines, such as, serotonin or 5-hydroxytryptamine (5-HT) and histamine.
Catecholamines use the amino acid tyrosine as the backbone for synthesis, as
shown in Figure 1. Briefly, tyramine is the rate-limiting product in the formation
of octopamine. Tyramine is produced by the decarboxylation of the amino acid
tyrosine via tyrosine decarboxylase (10). Tyramine can also be synthesized from
a dopamine metabolite; however, this is not believed to be a major synthetic
route (11). Tyramine is further acted upon by tyramine-β-hydroxylase to form
octopamine (12).
Figure 1. The amino acid, tyrosine, is vital to the synthesis of tyramine
and octopamine. Tyramine is synthesized when tyrosine decarboxylase
(TDC) converts tyrosine to tyramine. Octopamine is synthesized when
tyramine-β-hydroxylase (TβH) converts tyramine to octopamine. It is possible
that tyramine can be synthesized from a dopamine pathway when dihydroxy
phenylalanine is synthesized from tyrosine via tyrosine hydroxylase (TH).
Dihydroxy phenylalanine is converted to dopamine via DOPA decarboxylase.
Dopamine is converted to tyramine via dopamine dehydroxylase (DDH).
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Signal Transduction of Octopamine and Tyramine
Octopamine and tyramine are released from various portions of the insect’s
nervous system (11, 13). Octopamine and tyramine’s physiological functions
are realized when octopamine or tyramine binds to its specific membrane-bound
receptors. In turn, the receptor internalizes this original chemical message
into a biochemical cascade via the production of second messenger(s), which
ultimately results in a cellular response. Octopamine and tyramine primarily
activate the superfamily GPCRs. Specifically, octopamine and tyramine activate
rhodopsin-like metabotropic GPCRs. GPCRs are sometimes referred to as
heptahelical receptors or serpentine receptors; this is because the receptor
transverses the cell membrane seven times (7-TM). The seven transmembrane
regions of GPCRs are connected by three extracellular loops and three intracellular
loops. Residues in several octopamine receptors and several tyramine receptors
have been shown to be important in ligand binding and receptor function, which
has been discussed in a recent review (14). Receptor activation allows for the
recruitment of a heterotrimeric intracellular G-protein, which are composed of an
α -subunit, β-subunit and a γ-subunit.
The original classification of octopamine receptors was based on second
messenger production in various invertebrate tissues. However, the advent of
molecular biology has allowed for a comprehensive approach to octopamine
receptor classification, now including tyramine receptors as a separate entity. The
new classification system is based on sequence homology with the mammalian
adrenergic receptors and signaling properties (15). That is, octopamine receptors
are classified based on sequence similarities and the production of specific second
messenger pathways realized during receptor activation. The α-adrenergic-like
octopamine receptor (OctαR) shares a sequence homology with the mammalian
α-adrenergic receptor(s). Activation of OctαR results in an increase of the
intracellular calcium ([Ca2+]i) concentration, which is liberated from intracellular
calcium stores, like the endoplasmic reticulum or the sarcoplasmic reticulum, via
the activation of the inositol pathway. β-adrenergic-like octopamine receptors
(OctβRs) share sequence homology with the mammalian β-adrenergic receptor(s).
Activation of OctβRs results in the increase of the intracellular concentration of
cyclic adenosine monophosphate (cAMP), via activation of the membrane-bound
enzyme adenylate cyclase. It is not unusual for OctαRs and OctβRs to respond
to either octopamine or tyramine at different concentrations; this is probably
due to structure similarity between octopamine and tyramine. Ligand-agonist
coupling or ligand-trafficking, which is peculiarized as the activation of
different second-messenger pathways based on the ligand, has been reported for
octopamine and tyramine at a single receptor (16). Ligand-agonist coupling is
commonly found with the octopamine/tyramine or tyramine receptor, which were
later classified as tyramine-1 receptors (TAR1). When octopamine activates these
receptors, it can result in an increase of the intracellular concentration of calcium.
When tyramine activates TAR1, it can result in an inhibitory effect on adenylate
cyclase, decreasing the intracellular concentration of cAMP. It is now accepted
that tyramine is the preferred ligand of TAR1 (14, 17). Recently, tyramine-2
receptors (TAR2) have been identified, which are also specifically activated by
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tyramine, versus octopamine, and have been shown to result in the release of
calcium from intracellular stores (18, 19). Bayliss et al. has proposed a third class
of tyramine receptors (TAR3), which have a different pharmacological profile,
and result in an increase of intracellular cAMP, when heterologously expressed in
Chinese hamster ovary (CHO-K1) cells. Additionally, TAR3 seems to be specific
to Drosophila melanogaster, where it is expressed in the crop and eye of the adult
flies and the hindgut in larvae (17). The signal transduction pathways for these
GPCRs are shown in Figure 2.
Figure 2. Signal transduction of tyramine and octopamine G-protein-coupled
receptors (GPCRs). Here the cellular biochemical pathway is shown for the
α-adrenergic-like octopamine receptor (OctαR), the β-adrenergic-like octopamine
receptor (OctβR), the Type-1 tyramine receptor (TAR1), the Type-2 tyramine
receptor (TAR2) and the Type-3 tyramine receptor (TAR3). Activation of cellular
biochemical pathways results in an insect behavior or function. Abbreviations:
GDP, guanosine diphosphate; GTP, guanosine triphosphate; PLC,
phosphoinositide phospholipase C; PIP2, phosphatidylinositol-4,5-bisphosphate;
IP3, inositol-1,4,5-trisphosphate; DAG, diacyl glycerol; PKC, protein kinase C;
cAMP, cyclic adenosine monophosphate; PKA, protein kinase
Ligand-gated ion channels, like GPCRs, are transmembrane ion channels and
are involved in the flow of ions into or out of a cell upon the binding of a ligand or
chemical message. Recently, ligand-gated chloride channels that are preferentially
activated by tyramine have been identified in Caenorhabditis elegans, Cel
LGC-55 (20), and in Haemonchus contortus, Hco-LGC-55 (21). Cel-LGC-55
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appears to act on neck muscles to suppress head oscillation and promote backward
movement or reversal behavior in C. elegans (20). Hco-LGC-55 has been shown
to be expressed in all life stages of the parasite; expression may be reduced in the
adult male (21).
Octopamine and Tyramine: Diverse Physiologically Active
Biogenic Amines
There is a plethora of studies examining the physiological importance of
octopamine and its receptors in various invertebrates; this has been the topic of
several excellent reviews (11, 14, 15, 22–24), and therefore, will not be discussed
here. Tyramine and its receptors, on the other hand, have not had as much research
attention. This is largely because tyramine was initially thought to only be the
biosynthetic precursor to octopamine. Therefore, we will focus on the advances
made in understanding the physiological role of tyramine through a brief review
of the literature.
Insects undergo differential behavioral states using semiochemicals, and this
is extended to the complex interactions of social insects, like the honey bee, Apis
mellifera. Previous studies have indicated neurohormonal and neuromodulatory
effects on honey bee behavior to aid in the support of social hierarchy in the
bee hive (25–29). Previous studies have indicated that the honey bee queen
uses pheromones, which are produced and released from the mandibular gland
and/or the Dufur’s gland, to maintain a reproductive hierarchy in the colony
(30). The concentration of pheromones produced in the mandibular gland is
high in the queen bee, but low in the worker bees (31, 32). Recently, tyramine
has been shown to result in reproductive dominance over the fertility of the bee.
Specifically, tyramine has been shown to be involved in ovary development, and
pheromone production and secretion; specifically, a pheromone that is consistent
with a queen (33). Tyramine did not have effects opposite of octopamine,
which had been thought to be a major role of tyramine in insects (24). Instead
octopamine appears to be involved in cast differentiation and the production of
specific worker pheromones (26, 27, 33).
Insects are able to respond to environmental cues via a variety of
chemosensory organs. The molecular mechanism of odor reception in insects
has been recently reviewed (34). While octopamine and tyramine may not be
the original sensing signals, they are involved in the neuronal modulation of the
signal. A D. melanogaster mutant has been identified as having an olfactory
defect resulting in behavioral changes (reduced avoidance). It was determined
that this reduced avoidance was a result of a p-element upstream of the type-1
tyramine receptor (TAR1); this decreased the expression of the tyramine receptor.
This indicates that tyramine has a role in modulation of D. melanogaster sensory
processing (35). Mutation of the tyramine-β-hydroxylase (TβH) gene results
in an abnormally low concentration of octopamine with a high concentration
of tyramine. The decreased level of octopamine results in a poor locomotion
phenotype in D. melanogaster. For instance, TβH mutant larvae were described
as being slow and “pausing”, compared to wild-type, described as a decrease
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in linear translocation; this phenotype was recovered by feeding the larvae
octopamine (36). Tyramine was able to decrease flight, possibly via a central
motor pattern generator, in honey bees; this is an opposite effect of octopamine
(37). Tyramine has also been shown to affect egg laying, reversal movement and
head oscillations in C. elegans (38). It is important to note that more sensory
behavior effects, head oscillations and reversal movement, were observed via the
effects at the chloride-gated tyramine receptor (LGC-55) (20).
Octopamine has previously been reviewed to have effects in the reproductive
system of insects (11); however, tyramine also has such a role. It has been
demonstrated that there are tyraminergic innervations in the Locusta migratoria
oviduct muscles. Tyramine was shown to increase the amplitude of excitatory
junctional potentials and hyperpolarize the oviduct muscle; this effect was seen at
low concentrations of tyramine (39). Tyramine has also been reported to have an
effect on other types of muscles, specifically, muscles involved in insect flight.
In D. melanogaster, tyramine has been shown to inhibit flight initiation at high
concentrations (40).
Botanical Insecticides
Botanical insecticides, such as pyrethrum, rotenone, neem and plant essential
oils, have been used for over 150 years in the United States; however, some
botanical insecticides have been used for thousands of years in other countries
(e.g. China, Egypt, Greece and India). Essential oils can be characterized
as lipophilic liquids, which when isolated from the plant, display a strong
odor. Essential oils function as plant secondary metabolites, which means
they are not involved in the primary metabolism of the plant but still serve a
variety of functions; for instance they can deter herbivorial feeding (41, 42).
Essential oils are commonly obtained via steam distillation from various plant
tissues/organs or plant foliage under a variety of conditions (41–43). Essential
oils are a complex mixture of different chemistries including various types of
terpenes/terpenoids and related aromatic terpenoid compounds. Here we will use
“terpene” interchangeably with “terpenoid”. Since botanical compounds, like
essential oils, are widely found in everyday items, like cosmetics and fragrances,
food additives and pharmaceuticals, they are generally believed to have minimal
mammalian toxicity (44). Some essential oils and essential oil components are
found on the United States Environmental Protection Agency’s exempt lists (25b
and 4a). Additionally, some essential oils are Generally Recognized As Safe
(GRAS), according to the Food and Drug Administration (FDA).
Essential oil terpenoids are synthesized from isoprene units, which are the
five-carbon building blocks of terpenoids. The coupling of these isoprene units
can lead to structures that have 5 – 40 carbons. Here, we focus on terpenoid
structures composed of two isoprene units, monoterpenoids (10-carbons),
and terpenoid structures composed of three isoprene units, sesquiterpenoids
(15-carbons). The carbon backbone of terpenoids is further targeted by a variety
of enzymes that give terpenoids diverse characteristics. For instance, terpenoids
can be cyclic or acyclic, and they can contain a variety of heteroatoms to create
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alcohols, aldehydes, ketones, esters, epoxides, ethers, and acids (45–47). Not
all terpenoids are aliphatic; some related aromatic terpenoids are synthesized
from the shikimic acid pathway, which is the pathway that plants commonly use
to synthesize aromatic amino acids. In particular, phenylalanine and tyrosine
are responsible for the phenylpropane/phenylpropene units that are the building
blocks for the aromatic compounds found in essential oils (46).
Terpenoid Mechanism of Action: Focus on Octopamine and
Tyramine Receptors
An understanding of the mechanism of action of insecticidal activity of
essential oils, and their terpenoids, will aid in the integration of these compounds
into a pest control strategy. While several studies have indicated that these
compounds have a neurotoxic mechanism of action (48, 49), it is possible that
several targets or mechanisms are involved, both inside and outside of the
insect’s nervous system. Several studies have been performed assessing different
mechanisms of neurotoxic action. These studies included the compound’s ability
to inhibit the enzyme acetylcholinesterase, leading to an increased concentration
of acetylcholine in the synaptic cleft (50–55). Another study evaluated the
ability of essential oil components to affect chloride conductance by altering the
γ-aminobutyric acid (GABAA) receptor (56). Additionally, different modulations
of the GABAA receptor along with physicochemical properties, to predict
successful modulation of this GABAA receptor, have been described (57, 58).
Recently, binding at the house fly (Musca domestica) nicotinic acetylcholine
receptor (nAChR) has been reported (59). In addition to GABA and nAChR
receptors, essential oil terpenoids have also been reported to have an effect at
other ion channels. Specifically, essential oil terpenoids have been reported to
inhibit transient receptor potential (TRP) channels, which are important sensory
channels in humans (60).
Essential oil toxicity may be attributed to the multi-functionality of
octopamine, and now tyramine, to insect physiology. Application of essential
oil terpenoids may result in hyperactivity, hyperextension of extremities and
abdomen, knockdown, which can be followed by death. Homogenate of the
American cockroach (Periplaneta americana) nervous system resulted in an
increase of cAMP upon terpenoid application, leading the author to suggest that
toxicity was mediated via the octopaminergic system in the insect’s nervous
system (49). Later studies performed in Helicoverpa armigera homogenate
also showed an increase of cAMP (agonistic activity) from abdominal dermal
tissue with the application of several essential oil terpenoids, which was
blocked by the octopamine receptor antagonist, phentolamine (61). A cloned
α-adrenergic-like octopamine receptor (Pa oa1) has been described from the
American cockroach (49) and an α-adrenergic-like octopamine receptor (OAMB)
from D. melanogaster (62). When these octopamine receptors were expressed
in human embryonic kidney (HEK-293) cells they resulted in an increase of
the intracellular concentration of cAMP and calcium, which is peculiar since
these both are OCTαR’s and should signal via the inositol pathway (increase in
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intracellular calcium). This may be an artifact of the heterologous expression
system or this may indicate the ability of essential oils to recruit different
G-proteins, activating multiple second messenger pathways (23). When eugenol,
a plant essential oil monoterpenoid, was applied to HEK-293 cells expressing
Pa oa1 it decreased the basal level of cAMP. Application of trans-anethol to
HEK-293, expressing OAMB, resulted in an increase of the cellular concentration
of cAMP (62). However, little effect was reported on the calcium response
(62). Essential oil activity has also been reported on a cloned tyramine receptor,
from D. melanogaster that was expressed in Drosophila S2 cells. Here, a strong
calcium response, along with a decrease of forskolin-stimulated cAMP was
observed with the addition of tyramine (63). In addition to in vitro heterologous
expression studies performed for the D. melanogaster tyramine receptor; in vivo
studies were also performed to determine the toxicity of essential oil terpenoids
against D. melanogaster (63). The aromatic monoterpenoid, thymol, which was
the only tested monoterpenoid that resulted in an increase of the basal level of
cAMP, and an increase of the intracellular concentration of calcium resulted in
the lowest mortality (63). Thymol’s stereoisomer, carvacrol, which had a strong
calcium response against this D. melanogaster tyramine receptor, had similar
mortality to thymol (63). These results indicate a correlation between tyramine
receptor activity and insect mortality.
Conclusion
GPCRs have diverse physiological functions within invertebrates, including
insects, mites, ticks and nematodes; however, they are an underutilized target
for agrochemical development. Since GPCRs are a widely utilized target for the
pharmaceutical industry there are several screening systems available, which can
be applied to insects and ticks, to study GPCRs. The use of botanically-based
insecticides may allow for the development of efficacious biopesticide products or
serve as the starting material for safer arthropod and nematode control programs.
Hopefully GPCRs will be exploited as targets for insecticides or acaricides in the
future.
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